DAVID STONE: Open Payments
NPI 1871669838 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 57 payments from 24 companies in 2025. Trend: 2023 $1,409 · 2024 $1,199 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $235 |
| AstraZeneca Pharmaceuticals LP | 7 | $135 |
| PFIZER INC. | 5 | $98 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| ABIOMED | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Novo Nordisk Inc | 2 | $39 |
| Lilly USA, LLC | 2 | $34 |
Products named: AIRSUPRA, NURTEC ODT, VRAYLAR, UBRELVY, JARDIANCE, QULIPTA, XIFAXAN, TZIELD.
Industry payments across CA — which companies pay providers there.
